DIAGONAL THERAPEUTICS ANNOUNCES OVERSUBSCRIBED $125 MILLION SERIES B FINANCING TO ADVANCE CLINICAL DEVELOPMENT OF DISEASE-MODIFYING, CLUSTERING ANTIBODY PIPELINE

Reuters · 3d ago

Please log in to view news